These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 31802868

  • 1. Co-Administration Of iRGD Enhances Tumor-Targeted Delivery And Anti-Tumor Effects Of Paclitaxel-Loaded PLGA Nanoparticles For Colorectal Cancer Treatment.
    Zhong Y, Su T, Shi Q, Feng Y, Tao Z, Huang Q, Li L, Hu L, Li S, Tan H, Liu S, Yang H.
    Int J Nanomedicine; 2019; 14():8543-8560. PubMed ID: 31802868
    [Abstract] [Full Text] [Related]

  • 2. iRGD Co-Administration with Paclitaxel-Loaded PLGA Nanoparticles Enhance Targeting and Antitumor Effect in Colorectal Cancer Treatment.
    Li L, Yang M, Li R, Hu J, Yu L, Qian X.
    Anticancer Agents Med Chem; 2021; 21(7):910-918. PubMed ID: 32698755
    [Abstract] [Full Text] [Related]

  • 3. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment.
    Zhang Z, Qian H, Huang J, Sha H, Zhang H, Yu L, Liu B, Hua D, Qian X.
    Int J Nanomedicine; 2018; 13():4961-4975. PubMed ID: 30214200
    [Abstract] [Full Text] [Related]

  • 4. The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells.
    Gu G, Gao X, Hu Q, Kang T, Liu Z, Jiang M, Miao D, Song Q, Yao L, Tu Y, Pang Z, Chen H, Jiang X, Chen J.
    Biomaterials; 2013 Jul; 34(21):5138-48. PubMed ID: 23582684
    [Abstract] [Full Text] [Related]

  • 5. Mesenchymal stem cells loaded with paclitaxel-poly(lactic-co-glycolic acid) nanoparticles for glioma-targeting therapy.
    Wang X, Gao J, Ouyang X, Wang J, Sun X, Lv Y.
    Int J Nanomedicine; 2018 Jul; 13():5231-5248. PubMed ID: 30237710
    [Abstract] [Full Text] [Related]

  • 6. tLyP-1 Peptide Functionalized Human H Chain Ferritin for Targeted Delivery of Paclitaxel.
    Ma Y, Li R, Dong Y, You C, Huang S, Li X, Wang F, Zhang Y.
    Int J Nanomedicine; 2021 Jul; 16():789-802. PubMed ID: 33568906
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Folate-receptor-targeted laser-activable poly(lactide-co-glycolic acid) nanoparticles loaded with paclitaxel/indocyanine green for photoacoustic/ultrasound imaging and chemo/photothermal therapy.
    Liu F, Chen Y, Li Y, Guo Y, Cao Y, Li P, Wang Z, Gong Y, Ran H.
    Int J Nanomedicine; 2018 Jul; 13():5139-5158. PubMed ID: 30233177
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inhibitory potential of iRGD peptide-conjugated garcinol-loaded biodegradable nanoparticles in rat colorectal carcinoma.
    Paul B, Gaonkar RH, Dutta D, Dasi R, Mukherjee B, Ganguly S, Das SK.
    Biomater Adv; 2022 Mar; 134():112714. PubMed ID: 35581094
    [Abstract] [Full Text] [Related]

  • 12. CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer.
    Byeon Y, Lee JW, Choi WS, Won JE, Kim GH, Kim MG, Wi TI, Lee JM, Kang TH, Jung ID, Cho YJ, Ahn HJ, Shin BC, Lee YJ, Sood AK, Han HD, Park YM.
    Cancer Res; 2018 Nov 01; 78(21):6247-6256. PubMed ID: 30115698
    [Abstract] [Full Text] [Related]

  • 13. Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid-paclitaxel (CLA-PTX) on B16-F10 melanoma.
    Du R, Zhong T, Zhang WQ, Song P, Song WD, Zhao Y, Wang C, Tang YQ, Zhang X, Zhang Q.
    Int J Nanomedicine; 2014 Nov 01; 9():3091-105. PubMed ID: 25028548
    [Abstract] [Full Text] [Related]

  • 14. iRGD-Guided Silica/Gold Nanoparticles for Efficient Tumor-Targeting and Enhancing Antitumor Efficacy Against Breast Cancer.
    Hou X, Chen Q, Fang Y, Zhang L, Huang S, Xu M, Ren Y, Shi Z, Wei Y, Li L.
    Int J Nanomedicine; 2024 Nov 01; 19():8237-8251. PubMed ID: 39157735
    [Abstract] [Full Text] [Related]

  • 15. Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells.
    Zhang J, Wang L, Fai Chan H, Xie W, Chen S, He C, Wang Y, Chen M.
    Sci Rep; 2017 May 04; 7():46057. PubMed ID: 28470171
    [Abstract] [Full Text] [Related]

  • 16. iRGD-mediated core-shell nanoparticles loading carmustine and O6-benzylguanine for glioma therapy.
    Liu C, Yao S, Li X, Wang F, Jiang Y.
    J Drug Target; 2017 Mar 04; 25(3):235-246. PubMed ID: 27646474
    [Abstract] [Full Text] [Related]

  • 17. Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells.
    Mitra M, Misra R, Harilal A, Sahoo SK, Krishnakumar S.
    Mol Vis; 2011 Mar 04; 17():2724-37. PubMed ID: 22065926
    [Abstract] [Full Text] [Related]

  • 18. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy.
    Xu C, Liu W, Hu Y, Li W, Di W.
    Theranostics; 2020 Mar 04; 10(7):3325-3339. PubMed ID: 32194871
    [Abstract] [Full Text] [Related]

  • 19. iRGD conjugated TPGS mediates codelivery of paclitaxel and survivin shRNA for the reversal of lung cancer resistance.
    Shen J, Meng Q, Sui H, Yin Q, Zhang Z, Yu H, Li Y.
    Mol Pharm; 2014 Aug 04; 11(8):2579-91. PubMed ID: 24236909
    [Abstract] [Full Text] [Related]

  • 20. HPA aptamer functionalized paclitaxel-loaded PLGA nanoparticles for enhanced anticancer therapy through targeted effects and microenvironment modulation.
    Duan T, Xu Z, Sun F, Wang Y, Zhang J, Luo C, Wang M.
    Biomed Pharmacother; 2019 Sep 04; 117():109121. PubMed ID: 31252265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.